Key facts
- This page summarizes Richard J. Hawkins's Form 4 filing for PLUS THERAPEUTICS, INC. (PSTV).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Jul 2026, 16:30.
Richard J. Hawkins - 01 Jul 2026 Form 4 Insider Report for PLUS THERAPEUTICS, INC. (PSTV)
- Reporting relationship
- Director
- Issuer ticker
- PSTV
- Reported as of
- 01 Jul 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Jul 2026, 16:30:10 UTC
- Prior SEC filing
- 18 May 2026
- Source filing
- View source filing
- Reporting owner signature
- Andrew Sims, as attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Richard J. Hawkins filed Form 4 for PLUS THERAPEUTICS, INC. (PSTV) on 01 Jul 2026.
Change
- Previous filing in this sequence was filed on 18 May 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001307632
Primary reporting owner
Hawkins Richard J
- Relationship
- Director
- Address
- C/O PLUS THERAPEUTICS INC., 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON
- Signature
- Andrew Sims, as attorney-in-fact
- Signature date
- 01 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PSTV
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +922
- Change %
- +152%
- Price
- $0.000000*
- Shares after
- 1,529
- Date
- 01 Jul 2026
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PSTV
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -922
- Change %
- -25%
- Price
- $0.000000*
- Shares after
- 2,764
- Date
- 01 Jul 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 922
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the issuer's Common Stock.
Footnote F2
Represents the vesting of an RSU grant which occurs in four substantially equal quarterly installments beginning on July 1, 2026.